From:  The expanding spectrum of eosinophilic gastrointestinal disorders: summarizing diagnostic challenges, updated consensus diagnostic criteria, molecular drivers and site-specific histopathological changes

 Reported long-term outcomes in EGIDs.

EGID subtypeLong-term complicationsRelapse riskImpact on quality of life
Eosinophilic esophagitis (EoE)Fibrostenosis and strictures in 30–40% of untreated patients; food impaction riskHigh relapse is common after treatment withdrawalDysphagia, dietary restrictions, impaired social functioning
Eosinophilic gastritisGastric wall thickening, protein-losing enteropathy (rare)50% recurrence after corticosteroid taperingChronic abdominal pain, nausea, nutritional compromise
Eosinophilic enteritisMalabsorption, anemia, and occasional stricturesFrequent relapse, especially after drug cessationFatigue, weight loss, reduced work capacity
Eosinophilic colitisChronic diarrhea, occasional bleeding; less risk of stricturesRelapsing-remitting course in many patientsImpact on daily activities, anxiety related to chronic symptoms

EGIDs: eosinophilic gastrointestinal disorders.